Results 131 to 140 of about 131,822 (267)

Efficacy and safety of 2–4 mg brexpiprazole in the management of schizophrenia: A systematic review and meta‐analysis

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.
This graphical summary illustrates the efficacy and safety of brexpiprazole (2–4 mg) in patients with schizophrenia. The meta‐analysis demonstrates significant improvement in clinical outcomes, with reductions in Positive and Negative Syndrome Scale (PANSS) and Clinical Global Impression ‐ Severity scale (CGI‐S) scores, indicating better symptom ...
Sher Bano, Aashan Ahmad, Abdul Haseeb Mohammed, Ismailova Rushana Nurbekovna, Saja Saad, Noor Fatima, Muhammad Bilal Akbar, Zainab Salahuddin, Sadikun Nabi, Mohammad Mustafa Ababneh, Laiba Ajmal, Sidra Hariss, Hiba Manaf, Farah Saleh, Raouf Khan   +14 more
wiley   +1 more source

Stress Promotes Drug Seeking Through Glucocorticoid-Dependent Endocannabinoid Mobilization in the Prelimbic Cortex [PDF]

, 2018
Background Clinical reports suggest that rather than directly driving cocaine use, stress may create a biological context within which other triggers for drug use become more potent. We hypothesize that stress-induced increases in corticosterone “set the
Baker, David A., Cravatt, Benjamin F., Doncheck, Elizabeth M., Graf, Evan N., Hillard, Cecilia J., Li, Yan, Liu, Qing-Song, Mantsch, John R., McReynolds, Jayme R., Ogasawara, Daisuke, Vranjkovic, Oliver   +10 more
core   +1 more source

The importance of longitudinal evaluation using DAT‐SPECT in organophosphate‐induced toxic parkinsonism

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.
We performed longitudinal evaluation using magnetic resonance imaging (MRI) and dopamine transporter single‐photon emission computed tomography (DAT‐SPECT) in a case of organophosphate‐induced toxic parkinsonism. Fluid‐attenuated inversion recovery (FLAIR) images showed bilateral striatal hyperintensity in the acute phase, followed by reduction of ...
Shuhei Nakao, Yoichiro Kogoh, Hideki Funahashi, Yusei Yanoma, Minako Azuma, Yasushi Ishida, Yoji Hirano   +6 more
wiley   +1 more source

Clinical dilemma of mood stabilizer augmentation in treatment‐resistant schizophrenia with residual phase: A case report of valproate‐associated hypoglycemia and cytopenia, and subsequent lithium response

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.
Abstract Background Mood stabilizer augmentation is frequently used in treatment‐resistant schizophrenia despite limited guideline recommendations. Evidence for its efficacy and safety in the residual phase, however, remains insufficient. Case Presentation A 49‐year‐old Japanese woman with treatment‐resistant residual schizophrenia exhibited persistent
Yoshiki Kasagi, Naomichi Okamoto, Reiji Yoshimura   +2 more
wiley   +1 more source

Italian social psychiatry research: What gets published in peer reviewed journals? [PDF]

, 2007
Publisher version: http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=8264025&fulltextType=RA&fileId ...
Galeazzi, GM, Priebe, S
core  

Brivaracetam‐associated manic episode in a patient with bipolar disorder: A case report

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.
A patient with Bipolar I disorder developed manic symptoms following the initiation of brivaracetam for focal epilepsy. Although brivaracetam is generally considered to have favorable psychiatric tolerability, this case highlights a potential risk of mood destabilization in patients with underlying bipolar disorder.
Mihoko Kawai, Jun Miyata, Kousuke Kanemoto   +2 more
wiley   +1 more source

Effects of ebselen addition on emotional processing and brain neurochemistry in depressed patients unresponsive to antidepressant medication

Translational Psychiatry
Lithium is an effective augmenting agent for depressed patients with inadequate response to standard antidepressant therapy, but numerous adverse effects limit its use.
Fitri Fareez Ramli, Nisha Singh, Uzay E. Emir, Luca M. Villa, Shona Waters, Catherine J. Harmer, Philip J. Cowen, Beata R. Godlewska   +7 more
doaj   +1 more source

Translational psychopharmacology

Journal of Psychopharmacology, 2021
openaire   +3 more sources

CAT‐Hokkaido: A tablet‐based assessment of cognitive impairment in schizophrenia

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.
CAT‐Hokkaido is a brief tablet‐based cognitive assessment covering six neurocognitive domains relevant to schizophrenia. In patients with schizophrenia, it detected deficits in four of six tasks and showed significant correlations with corresponding MCCB measures, supporting its potential utility in assessing cognitive impairment.
Atsuhito Toyomaki, Hayato Watanabe, Ryo Sawagashira, Chiemi Kubota, Naoki Hashimoto, Takahiro A. Kato   +5 more
wiley   +1 more source

Effectiveness of the Early Start Denver Model (ESDM) as an early intervention for young children with autism spectrum disorder in clinical settings in Japan: A non‐randomized controlled trial

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.
Abstract Aim The Early Start Denver Model (ESDM), a core Naturalistic Developmental Behavioral Intervention (NDBI), promotes developmental gains in young children with autism spectrum disorder (ASD) through socially embedded learning. Because high‐intensity ESDM programs (approximately 20 h/week) are difficult to implement in many Japanese clinical ...
Yukie Tateno, Ryunosuke Monden, Kahoru Kumagai, Masaru Tateno   +3 more
wiley   +1 more source